Continuous culture of Cryptosporidium parvum using hollow fiber technology

International Journal for Parasitology

Volumn 46, Issue 1, 2016, Pages 21-29

  Morada, Mary ^a   Lee, Sangun ^b   Gunther Cummins, Leslie ^c   Weiss, Louis M ^c   Widmer, Giovanni ^b   Tzipori, Saul ^b   Yarlett, Nigel ^a  

^a PACE UNIVERSITY   (United States)

^b TUFTS UNIVERSITY   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Anaerobic; Cryptosporidium; Hollow fiber; In vitro culture

Indexed keywords

DEXAMETHASONE; OXYGEN; RNA 18S; FRESH WATER;

ANOXIC CONDITIONS; INFECTIVITY; PARASITE; PROTOZOAN; RODENT; TECHNOLOGY ADOPTION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTINUOUS CULTURE; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; HOLLOW FIBER; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; NUTRIENT; OOCYST; OXIDATION REDUCTION REACTION; PARASITE DEVELOPMENT; PARASITE VIRULENCE; ANIMAL; C57BL MOUSE; CELL CULTURE TECHNIQUE; CELL LINE; CYTOLOGY; DEVICES; DISEASE MODEL; FECES; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; PARASITOLOGY; PROCEDURES;

CRYPTOSPORIDIUM; CRYPTOSPORIDIUM PARVUM;

ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DEXAMETHASONE; DISEASE MODELS, ANIMAL; FECES; FEMALE; FRESH WATER; HOST-PATHOGEN INTERACTIONS; HUMANS; MICE; MICE, INBRED C57BL; OOCYSTS; RNA, RIBOSOMAL, 18S;

EID: 84961217931     PISSN: 00207519     EISSN: 18790135     Source Type: Journal    
DOI: 10.1016/j.ijpara.2015.07.006     Document Type: Article

References (38)

1. Abrahamsen M.S., Templeton T.J., Enomoto S., Abrahante J.E., Zhu G., Lancto C.A., Deng M., Liu C., Widmer G., Tzipori S., Buck G.A., Xu P., Bankier A.T., Dear P.H., Konfortov B.A., Spriggs H.F., Iyer L., Anantharaman V., Aravind L., Kapur V. Complete genome sequence of the apicomplexan, Cryptosporidium parvum. Science 2004, 304:441-445.
2. Abubakar I., Aliyu S.H., Arumugam C., Usman N.K., Hunter P.R. Treatment of cryptosporidiosis in immune-compromised individuals: systematic review and meta-analysis. Br. J. Clin. Pharmacol. 2007, 63:387-393.
3. Alcantara Warren C., Destura R.V., Sevilleja J.E., Barroso L.F., Carvalho H., Barrett L.J., O'Brien A.D., Guerrant R.L. Detection of epithelial cell injury and quantification of infection in the HCT8 organoid model of cryptosporidiosis. J. Infect. Dis. 2008, 198:143-149.
4. Arrowood M.J. In vitro cultivation. Cryptosporidium and Cryptosporidosis 2008, 499-525. CRC Press, Boca Raton, USA. second ed. R. Fayer, L. Xiao (Eds.).
5. Arrowood M.J., Sterling C.R. Isolation of Cryptosporidium oocysts and sporozoites using discontinuous sucrose and isopycnic percoll gradients. J. Parasitol. 1987, 74:314-319.
6. Bakshi R.P., Nenorlas E., Tripathi A.K., Sullivan D.J., Shapiro T.A. Model system to define pharmacokinetic requirements for antimalarial drug efficiency. Sci. Transl. Med. 2013, 5(205):205ra135. 10.1126/scitranslmed.3006684.
7. Banwat E.B., Egah D.Z., Onile B.A., Angyo I.A., Audu E.S. Prevalence of Cryptosporidium infection among undernourished children in Jos, Central Nigeria. Niger. Postgrad. Med. J. 2003, 10:84-87.
8. Bushkin G.G., Motari E., Carpentieri A., Dubey J.P., Costello E.E., Robbins P.W., Samuelson J. Evidence for a structural role for acid-fast lipids in oocyst walls of Cryptosporidium, Toxoplasma and Eimeria. MBio 2013, 4:e00387-e00413. 10.1128/mBio. 00387-13.
9. Carvalho H.M., Teel L.D., Goping G., O'Brian A.D. A three-dimensional tissue culture model for the study of attach and efface lesion formation by enteropathogenic and enterohaemorrhagic Escherichia coli. Cell. Microbiol. 2005, 7:1771-1781.
10. Cai X., Woods K.M., Upton S.J., Zhu G. Application of quantitative real-time reverse transcription-PCR in assessing drug efficacy against the intracellular pathogen Cryptosporidium parvum in vitro. Antimic. Ag. Chemother. 2005, 49:4437-4442.
11. Castellanos-Gonzalez A., Cabada M.M., Nichols J., Gomez G., White A.C. Human primary intestinal epithelial cells as an improved in vitro model for Cryptosporidium parvum infection. Infect. Immun. 2013, 81:1996-2001.
12. Checkley W., White A.C., Jaganath D., Arrowood M.J., Chalmers R.M., Chen X., Fayer R., Griffiths J.K., Guerrant R.L., Hedstrom L., Huston C.D., Kotloff K.L., Kang G., Mead J.R., Miller M., Petri W.A., Priest J.W., Roos D.S., Striepen B., Thompson R.C., Ward H.D., Van Voorhis W.A., Xiao L., Zhu G., Houpt E.R. A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for Cryptosporidium. Lancet Infect. Dis. 2014, 15(1):85-94.
13. Circu M.L., Aw T.Y. Redox biology of the intestine. Free Radical Res. 2011, 45:1245-1266.
14. Fayer R. General biology. Cryptosporidium and Cryptosporidosis 2008, 1-42. CRC Press, Boca Raton, USA. second ed. R. Fayer, L. Xiao (Eds.).
15. Hamedi Y., Safa O., Haidari M. Cryptosporidium infection in diarrheic children in southeastern Iran. Pediatr. Infect. Dis. J. 2005, 24:86-88.
16. Hieinz E., Lithgow T. Back to basics: revealing secondary reduction of the mitochondrial protein import pathway in diverse intracellular parasites. Biochim. Biophys. Acta 2013, 1833:295-303.
17. Jonas C.R., Ziegler T.R., Gu L.H., Jones D.P. Extracellular thiol/disulfide redox state affects proliferation rate in a human colon carcinoma (Caco2) cell line. Free Radical Biol. Med. 2002, 33:1499-1506.
18. Keithly J.S., Zhu G., Upton S.J., Woods K.M., Martinez M.P., Yarlett N. Polyamine biosynthesis in Cryptosporidium parvum and its implications for chemotherapy. Mol. Biochem. Parasitol. 1997, 88:35-42.
19. Kemp M., Go Y.M., Jones D.P. Non-equilibrium thermodynamics of thiol/disulfide redox systems: a perspective on redox systems biology. Free Radical Biol. Med. 2008, 44:921-937.
20. Kotloff K.L., Nataro J.P., Blackwelder W.C., Nasrin D., Faraq T.H., Panchalingam S., Wu Y., Sow S.O., Sur D., Breiman R.F., Farugue A.S., Zaidi A.K., Saha D., Alonso P.L., Tamboura B., Sanogo D., Onwuchekwa U., Manna B., Ramamurthy T., Kanungo S., Ochleng J.B., Omore R., Oundo J.O., Hossain A., Das S.K., Ahmed S., Qureshi S., Quadri F., Adegbola R.A., Antonio M., Hossain M.J., Akinsola A., Mandomando I., Nhampossa T., Acacio S., Biswas K., O'Reilly C.E., Mintz E.D., Berkeley L.Y., Muhsen K., Sommerfeit H., Robins-Browne R.M., Levine M.M. Burden and etiology of diarrheal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 2013, 382:209-222.
21. Liu L., Johnson H.L., Cousens S., Perin J., Scott S., Lawn J.E., Rudan I., Campbell H., Cibulskis R., Li M., Mathers C., Black R.E. Child Health Epidemiology Reference Group of WHO and UNICEF, 2012. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 2012, 379:2151-2161.
22. Ma P., Soave R. Three-step stool examination for cryptosporidiosis in 10 homosexual men with protracted watery diarrhea. J. Infect. Dis. 1983, 147:824-828.
23. Mathur M.K., Verma A.K., Makwana G.E., Sinha M. Study of opportunistic parasitic infections in human immunodeficiency virus/acquired immunodeficiency syndrome patients. J. Global Infect. Dis. 2013, 5:164-167.
24. Mazumdar J., Striepen B. Make it or take it: fatty acid metabolism of apicomplexan parasites. Eukaryotic Cell 2007, 6:1727-1735.
25. Meloni B.P., Thompson R.C. Simplified methods for obtaining purified oocysts from mice and for growing Cryptosporidium parvum in vitro. J. Parasitol. 1996, 82:757-762.
26. Mittal N., Morada M., Tripathi P., Gowri V.S., Mandal S., Quirch A., Park M.H., Yarlett N., Madhubala R. Cryptosporidium parvum has an active hypusine biosynthesis pathway. Mol. Biochem. Parasitol. 2014, 195:14-22.
27. Mølbak K., Højlyng N., Ingholt L., Da Silva A.P., Jepsen S., Aaby P. An epidemic outbreak of cryptosporidiosis: a prospective community study from Guinea-Bissau. Pediatr. Infect. Dis. 2013, 9:566-570.
28. Molloy S.F., Tanner C.J., Kirwan P., Asaolu S.O., Smith H.V., Nichols R.A., Connelly L., Holland C.V. Sporadic Cryptosporidium infection in Nigerian children: risk factors with species identification. Epidemiol. Infect. 2011, 239:946-954.
29. Morada M., Pendyala L., Wu G., Merali S., Yarlett N. Cryptosporidium parvum induces an endoplasmic stress response in the intestinal adenocarcinoma HCT-8 cell line. J. Biol. Chem. 2013, 288:30356-30364.
30. Niemand J., Louw A.L., Birkholtz L., Kirk K. Polyamine uptake by the intraerythrocytic malaria parasite, Plasmodium falciparum. Int. J. Parasitol. 2012, 42:921-929.
31. Sifuentes L.Y., DiGiovanni G.D. Aged HCT-8 cell monolayers support Cryptosporidium parvum infection. Appl. Environ. Microbiol. 2007, 73:7548-7551.
32. Striepen B. Parasitic infections: time to tackle cryptosporidiosis. Nature 2013, 503:189-191.
33. Upton S.J., Tilley M., Brillhart D.B. Comparative development of Cryptosporidium parvum (Apicomplexa) in 11 continuous host cell lines. FEMS Microbiol. Lett. 1994, 118:233-236.
34. Varughese E.A., Bennett-Stamper C.L., Wymer L.J., Yadav J.S. A new in vitro model using small intestinal epithelial cells to enhance infection of Cryptosporidium parvum. J. Microbiol. Met. 2014, 106:47-54.
35. Xiao L. Molecular epidemiology of cryptosporidiosis: an update. Exp. Parasitol. 2010, 124:80-89.
36. Yichoy M., Duarte T.T., De Chatterjee A., Mendez T.L., Aguilera K.Y., Roy D., Roychowdhury S., Aley S.B., Das S. Lipid metabolism in Giardia: a post-genomic perspective. Parasitology 2011, 138:267-278.
37. Zhu G. Biochemistry. Cryptosporidium and Cryptosporidosis 2008, 57-77. CRC Press, Boca Raton, USA. second ed. R. Fayer, L. Xiao (Eds.).
38. Zhu G., Shi X., Cai X. The reductase domain in a type I fatty acid synthase from the apicomplexan Cryptosporidium parvum: restricted substrate preferences towards very long chain fatty acyl thioesters. BMC Biochem. 2010, 11:46. 10.1186/1471-2091-11-46.